Published: 29 August 2022
Author(s): Mahnoor Sukaina, Marium Waheed, Naba Ali, Raffat Rasool
Section: Letter to the Editor

Hypertrophic cardiomyopathy (HCM) is a condition in which the myocardium is hypertrophied. HCM is the most common genetic cardiovascular disease and the most common cause of death in young adults [1]. The heart muscle thickens mostly in the septum and obstructs blood flow from the heart to the body Patients at risk of HCM, can be treated with prophylactic implantation of an implantable cardiac defibrillator (ICD). In addition, the treatment options for HOCM include beta-blocker or calcium channel blockers such as verapamil [2].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.